다슬기 protamex 가수분해물(MPH)의 항당뇨 기작 연구

키워드

참고문헌 (45)

1. 정현진, "약용식물의 추출방법에 따른 항산화 및 항당뇨 활성", 한국식품과학회지, 42(5), pp.571~577 (2010), 한국식품과학회
2. 허명록, "토후박 추출물의 항산화 및 항당뇨 활성", 한국약용작물학회지, 18(1), pp.34~39 (2010), 한국약용작물학회
3. "Global report on diabetes" (2006)[URL]
4. 황진택, "근육세포 배양 계 에서 Biochanin A의 항 당뇨 효능평가", KSBB Journal, 27(1), pp.57~60 (2012), 한국생물공학회
5. Yoo HJ, "Pharmacotherapy for postprandial hyperglycemia in Type 2 diabetes", J Korean Diabetes, 13, pp.39~43 (2012)
6. 박경수, "Multiple Low Dose Streptozotocin으로 유도된 당뇨 흰쥐에서백삼 , 홍삼, 화기삼의 항당뇨 활성 비교", Journal of Ginseng Research, 27(2), pp.3~61 (2003), 고려인삼학회
7. 이정민, "제2형 당뇨병에서 경구 혈당강하제제의 병합요법", 대한의사협회지, 57(5), pp.435~443 (2014), 대한의사협회[DOI]
8. 권은정, "진생베리 열수 추출물의 다당체 분해 효소와 인슐린 신호전달 분자 PTP1B와 AKT1에 미치는 효과", 생명과학회지, 24(9), pp.1006~1011 (2014), 한국생명과학회
9. 임선아, "항당뇨 물질 Aloe QDM complex의 세포내 포도당 흡수촉진 효능", 생약학회지, 44(1), pp.75~82 (2013), 한국생약학회
10. Eun Kyung Cho, "담쟁이덩굴 추출물과 분획물의 항산화, 항당뇨 및 항염증 효과", 생명과학회지, 23(3), pp.399~405 (2013), 한국생명과학회[DOI]
11. Kang TS, "Effects of Pleurotus eryngii on the blood glucose and cholesterol in diabetic rats", Korean J Mycol, 29, pp.86~90 (2001)
12. Kim YH, "Studies on the Nutritive Component of black snail(Semisulcospira libertina)", Bull Agric College Chonbuk Univ, 16, pp.101~105 (1985)
13. 김연계, "국내산 7종 다슬기 추출물의 생리활성 특성 비교", 한국수산과학회지, 42(5), pp.434~441 (2009), 한국수산과학회
14. Lee MS, "Hepatoprotective effects of the water extract from Semisulcospira gottschei against liver injuries induced by carbon tetrachloride in rats", J Korean Soc Hyg Sci, 11, pp.17~26 (2005)
15. 박영미, "다슬기 열수 추출물이 간독성이 유도된 흰쥐에 미치는 보호 효과", 생명과학회지, 25(5), pp.539~547 (2015), 한국생명과학회
16. 임치원, "한국산 다슬기의 식품학적 성분 및 품질특성", 한국수산과학회지, 42(6), pp.555~560 (2009), 한국수산과학회
17. 이문희, "한국산 다슬기류 (Semisulcospira spp.) 5종의 항산화 활성", 한국수산과학회지, 43(3), pp.188~194 (2010), 한국수산과학회
18. Choi JS, "Blood glycemia-modulating effects of melanian snail protein hydrolysates in mice with type II diabetes", Int J Mol Med, 39, pp.1437~1451 (2017)
19. AOAC, "Official Methods of Analysis", Association of Official Analytical Chemists, 69~74 (1995)
20. Scopes RK, "Protein Purification: Principles and Practice", pp.279~280 (1987), Springer-Verlag
21. Shim TH, "Comparison of lipid and amino acid in Semisulcospira gorrschei tissue", J Food Hyg Saf, 9, pp.81~87 (1994)
22. 정윤화, "실크단백질 효소 가수분해물이 2형 당뇨 마우스의 혈당 및 혈청지질에 미치는 영향", 한국식품영양과학회지, 35(10), pp.1343~1348 (2006), 한국식품영양과학회
23. 정용진, "전두유의 가수분해조건에 따른 이화학적 특성 변화", 한국식품저장유통학회지, 14(4), pp.394~399 (2007), 한국식품저장유통학회
24. "Diabete and therapeutic agents for glycemic control in diabetes mellitus, Report of Korea Drug Development Fund" (2013)[URL]
25. Koren S, "Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus", Best Pract Res Clin Endocrinol Metab, 21, pp.621~640 (2007)
26. Kulkarni RN, "Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes", Cell, 96, pp.329~339 (1999)
27. Lee J, "The insulin receptor: structure, function, and signaling", Am J Physiol, 266, pp.C319~C334 (1994)
28. Saltiel AR, "Insulin signalling and the regulation of glucose and lipid metabolism", Nature, 414, pp.799~806 (2001)
29. 김상미, "짚신나물 열수 추출물의 α-Glucosidase 저해 효과 및근육세포에서 포도당 이용에 미치는 영향", 한국식품영양학회지, 26(4), pp.806~813 (2013), 한국식품영양학회[DOI]
30. Yip SC, "PTP1B : a double agent in metabolism and oncogenesis", Trends Biochem Sci, 35, pp.442~449 (2010)
31. Panzhinskiy E, "Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus", Curr Med Chem, 20, pp.2609~2625 (2013)
32. van Huijsduijnen RH, "Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs", J Med Chem, 247, pp.4142~4146 (2004)
33. Elchebly M, "Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene", Sci, 283, pp.1544~1548 (1999)
34. Malamas MS, "New azolidinediones as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties", J Med Chem, 43, pp.995~1010 (2000)
35. 최철수, "인슐린저항성의 발생기전", 대한내과학회지, 77(2), pp.171~177 (2009), 대한내과학회
36. Winer DA, "The intestinal immune system in obesity and insulin resistance", Cell Metab, 23, pp.413~426 (2016)
37. Boden G, "Obesity, insulin resistance and free fatty acids", Curr Opin Endocrinol Diabetes Obes, 18, pp.139~143 (2011)
38. Li HB, "Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1", PI3K, Braz J Med Biol Res, pp.2015, 48[DOI]
39. Pauli JR, "Acute exercise reverses aged-induced impairments in insulin signaling in rodent skeletal muscle", Mech Ageing Dev, 131, pp.323~329 (2010)
40. Gonzalez-Rodriguez A, "Inhibition of PTP1B restores IRS1-mediated hepatic insulin signaling in IRS2-deficient mice", Diabetes, 59, pp.588~599 (2010)
41. Zabolotny JM, "Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo", J Biol Chem, 283, pp.14230~14241 (2008)
42. Zhao M, "Astragalus polysaccharide improves palmitate-induced insulin resistance by inhibiting PTP1B and NF-kappaB in C2C12 myotubes", Molecules, 17, pp.7083~7092 (2012)
43. Nieto-Vazquez I, "Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-α-induced insulin resistance", Diabetes, 56, pp.404~413 (2007)
44. Delibegovic M, "Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B", Mol Cell Biol, 27, pp.7727~7734 (2007)
45. Unger RH, "Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes", Diabetologia, 28, pp.119~121 (1985)

관련 논문AI추천